Beginning as early as 2014, the surgical technique patented by Dr. Wesley will receive FDA Approval and be made available to patients worldwide. Using this innovative approach, the benefits of current surgical practices (hair survival and natural appearance) may be enhanced and the appearance of scarring may be eliminated. In addition, post-operative recovery may be improved by becoming more comfortable and more rapid.
While Follicular Unit Extraction (FUE) represents a technical improvement in the field, the novel surgical approach developed by Dr. Wesley will more profoundly benefit patients undergoing modern hair transplantation.
|Direct Comparison of FUE and Scarless Surgery|
|Demands a high surgical skill level|
|Maximal transplanted hair survival by minimizing FU transection upon harvesting|
|Eliminates the stigma of small punctate scars|
|Broadens patient candidacy (curly hair)|
|Easy and comfortable post-operative recovery process as compared to “strip” surgery|
|Patients can wear their hair at any length they would like prior to surgery|
|Eliminates folliculitis from “buried” grafts|
|Subsequent surgeries are not hampered by fibrotic tissue from a prior session|
|FU are immediately stored in a viability-enhancing solution.|
|The handling of FU is limited to only gentle placement; thus enhancing survival|
|The protective tissue around each FU is maximized; thus enhancing survival.|
|Careful selection is the specific type and caliber of FU can be achieved; thus tailoring each session to fit the patients needs|
An initial clinical trial was conducted during the fall of 2011. The clinical trial had three (3) main objectives. To demonstrate:
In the following video presentation Dr. Wesley describes the background of the piloscopic scarless hair follicle harvesting technique and highlights the exciting results from the double-blind, 16-month clinical trial that demonstrate a significant advantage in transplanted hair follicle survival using the scarless approach to the traditional FUE method.
This password-protected video can be viewed using the password: “piloscopy”.
As the surgical instrumentation development process moves forward, we anticipate an additional clinical trial to be initiated in the late spring of 2014. Participating patients benefit from receiving approximately 100 transplanted hair follicles at no charge. If you are interested in learning more about enrolling in the upcoming clinical trial, please visit the website of the scarless surgery development project: www.pilofocus.com.